Journal of Drug Resistant Pathogen Research

Aims and Scope

Journal of Drug Resistant Pathogen Research (JDRPR) is a leading open-access, peer-reviewed forum dedicated to advancing our understanding of drug-resistant pathogens. Our mission is to illuminate the complex mechanisms behind microbial resistance and to foster the development of innovative strategies for the prevention, diagnosis, and treatment of drug-resistant infections worldwide.
 

Scope & Focus Areas: JDRPR welcomes high-quality, original research and reviews that address both the basic and applied aspects of drug-resistant microorganisms. Our dynamic scope includes, but is not limited to, the following themes:

• Diverse disciplines covered, such as microbiology, infectious disease, and drug discovery
• Focus on drug-resistant pathogens, drug toxicity, and resistance pathways
• Manuscripts related to obstructive antimicrobial resistance and novel immunological approaches welcomed
• Translation of proteomic work and new drug delivery routes explored
• Research on resistance mechanisms, alternative drug regimens, and microbial interactions encouraged
• Focus on bacterial diseases, antibiotic resistance, and control strategies
• Topics include epidemiology, diagnosis, prevention, and treatment of drug-resistant infections
• Research on antibacterial treatments, drug delivery, and resources for drug discovery
• Exploration of new approaches to combat bacteria, such as resequencing, antimicrobial peptides, and therapeutic phages
• Scope includes infections, viruses, incidence, mortality, habits, lifestyle, genital warts, genetics, food and nutrition, experimental studies, drug targeting, sensitivity and resistance, diagnostic techniques, and biomarkers
   

JDRPR encourage submissions that explore the use of artificial intelligence (AI) in drug discovery, personalized medicine, and other innovative approaches to combat drug-resistant pathogens. Contributions from the following research areas are invited but not limited to the following branches 

• Epidemiology
• Metabolism
• Acinetobacter baumannii
• Pathophysiology
• Medication
• Bacteriophage
• Enterobacteriaceae
• Multidrug resistance
• Antibiotic use
• Photothermal therapy
• Incidence and mortality
• Mechanisms of drug resistance
• Infection control strategy
• Drug-resistant pathogens
• Multi-drug resistant pathogens
• Superbugs
• Methicillin-resistant staphylococcus aureus (mrsa)
• Vancomycin-resistant enterococci (vre)
• Carbapenem-resistant enterobacteriaceae (cre)
• Phage therapy
• Multi-drug resistant tuberculosis (mdr-tb)
• Extensively drug-resistant tuberculosis (xdr-tb)
• Drug-resistant hiv
• Drug-resistant malaria
• Drug-resistant gonorrhea
• Drug-resistant urinary tract infections (utis)
• Drug-resistant respiratory infections
• Drug-resistant fungal infections
• Drug-resistant viral infections
• Mechanisms of antibiotic resistance
• Antimicrobial peptides
• Horizontal gene transfer
• Antibiotic stewardship
• Antibiotic misuse and overuse
• Antibiotic discovery and development
• New antibiotics
• Antibiotic combinations
• Antibiotic resistance testing
• Rapid diagnostic tests for drug-resistant infections
• Genomic sequencing for drug-resistant pathogens
• Surveillance for drug-resistant pathogens
• Prevention and control of drug-resistant infections
• Infection control practices
• Personal protective equipment
• Vaccines for drug-resistant pathogens
• Alternative therapies for drug-resistant infections
• Bacteriophages for drug-resistant pathogens
• Immunotherapies for drug-resistant infections
• Host-directed therapies for drug-resistant infections
• Novel targets for drug development
• Virulence factors of drug-resistant pathogens
• Host-pathogen interactions in drug-resistant infections
• Biofilms and drug-resistant infections
• Microbiome and drug-resistant infections
• Global burden of drug-resistant infections
• Economic impact of drug-resistant infections
• Policy and regulation for addressing drug-resistant infections
• Public health campaigns for antibiotic stewardship
• One health approach to drug-resistant infections
• Veterinary medicine and drug-resistant infections
• Foodborne pathogens and drug resistance
• Environmental reservoirs of drug-resistant pathogens
• Surveillance in agriculture and food production
• Emerging threats of drug-resistant infections